A mid-cap Pharma stock has become the favourite of several ace stock pickers because of it’s dominance in the market place, high RoEs, quality management and reasonable valuations. The stock is also proclaimed as a potential 100-bagger stock. Daljeet Kohli claims the stock is a good buy now because it is “ripe for re-rating“
We need to complement Raamdeo Agrawal’s Wealth Creation Study & Daljeet Kohli for handing over multibaggers to us over a platter. A mid-cap Pharma stock identified by these stalwarts surged 20% today and is en-route to effortlessly delivering the promised returns
Recent Comments